TNGX CIK: 1819133

Tango Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.2
FY22:
−111
FY23:
−114
FY24:
−146
FY25:
−111
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.3
FY22:
−109
FY23:
−112
FY24:
−143
FY25:
−109
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.9
FY22:
−108
FY23:
−102
FY24:
−130
FY25:
−102
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.2
FY22:
−108
FY23:
−102
FY24:
−130
FY25:
−102

All amounts in millions USD Data sources:SEC EDGARTwelve Data